Did you lose money on BSX? Class Action deadlines approaching.

NEW YORK, March 31, 2026 – Pomerantz LLP has announced the filing of a class action lawsuit against Boston Scientific Corporation (NYSE: BSX).

The legal firm is advising investors who may have been affected to contact Danielle Peyton. Inquiries can be made by emailing newaction@pomlaw.com or by calling 646-581-9980, or the toll-free number 888.4-POMLAW, extension 7980. Those reaching out via email are encouraged to include their mailing address, telephone number, and the total number of Boston Scientific shares they acquired.

Based on Ranked Stocks' quantitative analysis, Boston Scientific (BSX) currently holds an RS Score of 48.53, placing it in the 3.53rd percentile within both its country and sector. A key strength for the company is its Profitability, scoring 84.22. However, other performance metrics appear weaker, with Valuation at 13.21, Growth at 22.13, Momentum at 7.56, and EPS Revisions at 70.00. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.